E-LIB Suche - Ergebnisse für: Folschweiller, Nicolas

1

Immunogenicity, safety, and efficacy of a tetravalent dengu..:

Borja-Tabora, Charissa ; Fernando, LakKumar ; Lopez Medina, Eduardo...
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

2

Long-term efficacy and safety of a tetravalent dengue vacci..:

Tricou, Vianney ; Yu, Delia ; Reynales, Humberto...
The Lancet Global Health. 12 (2024) 2 - p. e257-e270 , 2024

Link: https://doi.org/10.1016/..

3

Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-00..:

Sirivichayakul, Chukiat ; Biswal, Shibadas ; Saez-Llorens, Xavier...
The Journal of Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

4

Safety and immunogenicity of a respiratory syncytial virus ..:

Kotb, Shady ; Haranaka, Miwa ; Folschweiller, Nicolas...
Respiratory Investigation. 61 (2023) 2 - p. 261-269 , 2023

Link: https://doi.org/10.1016/..

5

Bridging the immunogenicity of a tetravalent dengue vaccine..:

LeFevre, Inge ; Bravo, Lulu ; Folschweiller, Nicolas...
npj Vaccines. 8 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

6

Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequent..:

Sáez-Llorens, Xavier ; Biswal, Shibadas ; Borja-Tabora, Charissa...
The American Journal of Tropical Medicine and Hygiene. 108 (2023) 4 - p. 722-726 , 2023

Link: https://doi.org/10.4269/..

7

A randomized phase 3 trial of the immunogenicity and safety..:

Tricou, Vianney ; Eyre, Susannah ; Ramjee, Mahadev...
Vaccine. 41 (2023) 7 - p. 1398-1407 , 2023

Link: https://doi.org/10.1016/..

8

97. Tetravalent Dengue Vaccine (TAK-003) Development Progra..:

Tricou, Vianney ; Biswal, Shibadas ; Liu, Mengya...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S61-S61 , 2021

Link: https://doi.org/10.1093/..

9

Efficacy of AS04-Adjuvanted Vaccine Against Human Papilloma..:

Tota, Joseph E ; Struyf, Frank ; Hildesheim, Allan...
The Journal of Infectious Diseases. 223 (2020) 9 - p. 1576-1581 , 2020

Link: https://doi.org/10.1093/..

10

Long‐term persistence of immune response to the AS04‐adjuva..:

Hu, Yuemei ; Zhang, Xiang ; He, Yilin...
Asia-Pacific Journal of Clinical Oncology. 16 (2020) 6 - p. 392-399 , 2020

Link: https://doi.org/10.1111/..

11

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/1..:

Folschweiller, Nicolas ; Teixeira, Julio ; Joshi, Smita...
EClinicalMedicine. 23 (2020) - p. 100353 , 2020

Link: https://doi.org/10.1016/..

12

Long-term Cross-reactivity Against Nonvaccine Human Papillo..:

Folschweiller, Nicolas ; Behre, Ulrich ; Dionne, Marc...
The Journal of Infectious Diseases. 219 (2019) 11 - p. 1799-1803 , 2019

Link: https://doi.org/10.1093/..

13

Persistence of HBsAg‐specific antibodies and immune memory ..:

Van Damme, Pierre ; Dionne, Marc ; Leroux‐Roels, Geert...
Journal of Viral Hepatitis. 26 (2019) 9 - p. 1066-1075 , 2019

Link: https://doi.org/10.1111/..

14

Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled An..:

Tota, Joseph E ; Struyf, Frank ; Sampson, Joshua N...
JNCI: Journal of the National Cancer Institute. 112 (2019) 8 - p. 818-828 , 2019

Link: https://doi.org/10.1093/..

15

A ten-year study of immunogenicity and safety of the AS04-H..:

Schwarz, Tino F. ; Huang, Li-Min ; Valencia, Alejandra...
Human Vaccines & Immunotherapeutics. 15 (2019) 7-8 - p. 1970-1979 , 2019

Link: https://doi.org/10.1080/..